MedPath
FDA Approval

Octreotide acetate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Wockhardt Limited
DUNS: 650069115
Effective Date
October 10, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Octreotide(1000 ug in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Wockhardt Limited

650069115

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Wockhardt Limited

Wockhardt Limited

Wockhardt Limited

676257570

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Octreotide acetate

Product Details

NDC Product Code
55648-632
Application Number
ANDA090986
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
September 13, 2012
Code: 75R0U2568IClass: ACTIMQuantity: 1000 ug in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACT
PHENOLInactive
Code: 339NCG44TVClass: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath